Hematología y Hemoterapia

Resultados: 392
Tipo Título / Nombre Autor(es) Año
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderly multiple myeloma Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, et al 2016
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines Lozano ML, Revilla N, González-López TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, et al 2016
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, et al 2016
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Sánchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, et al 2016
Seguridad Transfusional y efectos adversos: protocolos y actuaciones Ibáñez Espacio F, Lanzas Merino F 2015
Seguridad transfusional y efectos adversos Ibáñez Espacio F, Lanzas Merino 2015
Púrpura Trombótica Trombocitopénica Ibáñez Espacio F 2015
Usefulness of Eltrombopag in Secondary ITP Patients in Clinical Practice Gonzalez Lopez TJ, Alvarez Roman MT, Pascual C, Sanchez Gonzalez B, Fernandez Fuentes F, Bermejo N [et al.] 2015
Bortezomib Plus Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) in Newly Diagnosed Elderly Myeloma Patients Overcome the Poor Prognosis of High-Risk Cytogenetic Abnormalities (CA) Detected By Fluorescence in Situ Hibridizati Mateos MV, Gutierrez NC, Martín ML, Martínez López J, Hernández MT, Martínez R, et al 2015
High Correlation Clinical Responses to 1st Line Acute Myeloid Leukemia Treatment with an Ex Vivo Native Environment Precision Medicine Test Montesinos P, Ballesteros J, Martinez Cuadrón D, Martínez López J, Serrano J, Pérez de Oteyza J, et al 2015